Breaking News
Investing Pro 0
🚨 NDVA surged 43%. This AI Chipmaker Could Be Next See Analysis

COVID-19 Vaccine Trials Boost Sentiment, RBNZ Decides on Rates

By JFD TeamMarket OverviewNov 10, 2020 03:37AM ET
www.investing.com/analysis/covid19-vaccine-trials-boost-sentiment-rbnz-decides-on-rates-200544084
COVID-19 Vaccine Trials Boost Sentiment, RBNZ Decides on Rates
By JFD Team   |  Nov 10, 2020 03:37AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
 
JP225
+0.37%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
BNTX
+0.70%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
ZM
+2.21%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
SSEC
+0.45%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
KS11
-0.29%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
IXIC
-0.63%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

Equities around the globe rallied yesterday after Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) said that their experimental vaccine was more than 90% effective in preventing COVID-19. The news came on top of Joe Biden’s victory in the US elections and helped Dow Jones and S&P 500 hit new record highs.

As for tonight, during the Asian morning Wednesday, the RBNZ decides on monetary policy. We don’t expect any policy changes, thus, we will look for clues and hints with regards to officials’ future plans.

Global Equities Skyrocket On Positive Vaccine News

The US dollar traded mixed against the other G10 currencies on Monday and during the Asian morning Tuesday. It gained against CHF, JPY, EUR, and AUD in that order, while it underperformed versus NOK and NZD. The greenback was found virtually unchanged against GBP, CAD, and SEK.

USD performance G10 currencies
USD performance G10 currencies

The weakening of the safe-havens franc and yen, combined with the strengthening of the oil-related NOK and the risk-linked Kiwi, suggests that markets continued trading in a risk-on manner. Indeed, major EU indices skyrocketed on average 6.26% each, while in the US, both the Dow Jones and the S&P 500 gained 2.95% and 1.17% respectively, hitting new intraday records. On the other hand, the tech-heavy NASDAQ slid 1.53%.

Today, in Asian, market appetite was somewhat softer, with Japan’s Nikkei 225, Hong Kong’s Hang Seng, and South Korea’s KOSPI rising only 0.26%, 0.70%, and 0.23% respectively. China’s Shanghai Composite was down 0.40%.

Major global stock indices performance
Major global stock indices performance

The rally in most equities came after Pfizer. and BioNTech said that their experimental vaccine was more than 90% effective in preventing COVID-19. Sectors which were hit the hardest by restrictive measures aimed at curbing the virus, like energy, travel and financials, were among the biggest gainers, with oil prices surging as well on expectations that demand would rise again, as people may become more comfortable with the idea of traveling soon. On the other hand, stocks that outperformed during the pandemic, like Netflix (NASDAQ:NFLX), Amazon (NASDAQ:AMZN), and Zoom (NASDAQ:ZM), fell sharply. That’s why NASDAQ was the only US index to close in negative waters.

Equity indices around the globe were already trending north on expectations that US President-elect Joe Biden will adopt a softer stance than Trump in handling the trade relationships of the US with the rest of the world. US indices were also on the rise, as a Republican-controlled Senate may not allow Biden to proceed with increasing corporate taxes and tightening regulations.

As for our view, it is still too early to start cheering that the COVID-era is behind us. There are still many questions with regards to the vaccine to be answered, such as how effective is by age or how long immunity could last. That may have been the reason behind the profit-taking correction we saw a few hours after the rally triggered by the positive vaccine news. 

Having said all that though, we are a step closer than yesterday in finding the cure for this virus, which combined with Biden’s victory, may allow investors to jump back into the action and push risk-linked assets back up. We would treat any further declines as a corrective pullback of the broader uptrend.

Euro Stoxx 50 Technical Outlook

Yesterday, the Euro Stoxx 50 index moved sharply to the upside, breaking above its medium-term downside resistance line taken from the high of July 21. The price came very close to testing the highest point of July, at 3450, but retraced back down a bit. Although, at some point, we might see a bit of a correction lower, overall, we will continue aiming higher.

Another push higher could bring the price to the above-mentioned 3450 barrier, which might be seen as a strong resistance area for a while. If so, the index may correct slightly lower, but if it is able to stay somewhere above the aforementioned downside line, that could keep the bulls interested. The buyers might then raise Euro Stoxx 50 again and if this time the 3450 hurdle surrenders, the next possible target may be the 3527 level, marked by the high of Feb. 27.

In order to shift our attention to some lower areas, we would prefer to wait for a drop back below the previously discussed downside line and below the 3222 zone, which is marked near the highs of Nov. 5 and 6. The bulls might flee the field and allow more bears to join in. Euro Stoxx 50 could travel to the 3132 obstacle, a break of which might set the stage for a move to the 3013 level, marked by the low of Nov. 4.

Euro stoxx 50 daily chart technical analysis
Euro stoxx 50 daily chart technical analysis

RBNZ Decides ON Monetary Policy

As for tonight, during the Asian morning Wednesday, the RBNZ decides on monetary policy. When they last met, policymakers of this Bank kept their Official Cash Rate (OCR) and their Large-Scale Asset Purchase (LSAP) program unchanged, repeating that further monetary stimulus may be needed in the foreseeable future, including a Funding for Lending Program, a negative OCR, and purchases of foreign assets.

RBNZ interest rates
RBNZ interest rates

That said, a few weeks ago, RBNZ Assistant Governor Christian Hawkesby said that some economic data has surprised to the upside, reducing the chances for the adoption of negative interest rates by this Bank. However, he added that the discussion of negative rates is “not a game of bluff”, keeping the prospect well on the table. With that in mind, we don’t expect the Bank to act at this gathering, but we do expect it to keep the prospect of further easing well on the table. Officials’ willingness to take interest rates into the negative territory if needed may hurt somewhat the Kiwi, but we expect the currency to stay mostly linked to developments surrounding the broader market sentiment. If the risk-on trading due to the COVID vaccine news and due to outcome of the US elections continues, any RBNZ-related slide may stay limited and short-lived, with the risk-linked currency rebounding and extending its latest short-term uptrend.

NZD/CHF Technical Outlook

NZD/CHF had a good run to the upside, yesterday, moving further away from its short-term upside support line drawn from the low of Oct. 20. The pair found some resistance near the 0.6246 barrier, which is an intraday swing low of June 8th and marked by an intraday swing high of June 9. Even though we might see a bit of a correction lower, still, if the above-mentioned upside line remains intact, we will stay positive, at least with the near-term outlook.

If the 0.6246 barrier continues to provide some resistance for now, we might see the rate correcting a bit lower. However, if the pair stays above the aforementioned upside line, the bulls could step in and try to take back control. If so, NZD/CHF may climb higher again, break the 0.6246 hurdle and aim for the next possible resistance area, at 0.6298. That area is the highest point of June.

Alternatively, if the previously-mentioned upside line breaks, that could spook the bulls from the field. NZD/CHF may then get picked up by more bears, who could drive it to the 0.6090 obstacle, or to the 0.6062 zone, marked by the low of November 4. The pair might rebound somewhat from zone, but if it can’t move back above the aforementioned upside line, another slide might be possible. The rate may drift back to the 0.6062 obstacle, a break of which could open the door for a move towards even lower areas. That’s when we will aim for the 0.6037 hurdle, or the 0.6008 level, marked by an intraday swing low of Oct. 21.

NZD/CHF 4-horu chart technical analysis
NZD/CHF 4-horu chart technical analysis

As For Today's Events

During the early European morning, we already got the UK employment report for September. The unemployment rate rose to 4.8% from 4.5%, but both the including and excluding bonuses earnings rates rose by more than anticipated.

From Germany, we have the ZEW survey for November. Both the current conditions and economic sentiment indices are expected to have declined, to -65.0 and 40.0 from -59.5 and 56.1. At its latest meeting, the ECB noted that in December, the new macroeconomic projections will allow a thorough reassessment of the economic outlook and that the Governing Council will recalibrate its instruments as appropriate. In other words, the ECB is very likely to expand its stimulative efforts in December, and declining ZEW indices will only add to that likelihood.

Later in the day, from the US, we get the JOLTs job openings for September and the API report on crude oil inventories for last week.

As for the speakers, we have only one on today’s agenda and this is Fed Board Governor Randal Quarles.

COVID-19 Vaccine Trials Boost Sentiment, RBNZ Decides on Rates
 

Related Articles

COVID-19 Vaccine Trials Boost Sentiment, RBNZ Decides on Rates

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email